摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2S,2'S)-oxybis(propane-2,1-diyl)bis(4-methylbenzenesulfonate) | 171753-73-4

中文名称
——
中文别名
——
英文名称
(2S,2'S)-oxybis(propane-2,1-diyl)bis(4-methylbenzenesulfonate)
英文别名
[(2S)-2-[(2S)-1-(4-methylphenyl)sulfonyloxypropan-2-yl]oxypropyl] 4-methylbenzenesulfonate
(2S,2'S)-oxybis(propane-2,1-diyl)bis(4-methylbenzenesulfonate)化学式
CAS
171753-73-4
化学式
C20H26O7S2
mdl
——
分子量
442.554
InChiKey
BKKNILNYOJKUJE-ROUUACIJSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    587.7±45.0 °C(Predicted)
  • 密度:
    1.256±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    29
  • 可旋转键数:
    10
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    113
  • 氢给体数:
    0
  • 氢受体数:
    7

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Preparation of optically active azophenolic crown ethers containing 1-phenylethane-1,2-diol and 2,4-dimethyl-3-oxapentane-1,5-diol as a chiral subunit: temperature-dependent enantiomer selectivity in the complexation with chiral amines 1
    摘要:
    采用(2S,4S)-2,4-二甲基-3-氧戊烷-1,5-二醇和(S)-或(R)-1-苯乙烷-1,2-二醇作为手性子单元,合成了具有两个苯基和两个甲基取代基以及p-(2,4-二硝基苯基偶氮)酚基团的光学活性偶氮酚类冠醚(S,S,S,S)-1、(R,S,S,R)-2、(S,S,S,S)-3和(R,S,S,R)-4,并且这些化合物以对映体纯形式制备。通过在氯仿中采用紫外-可见光光谱法研究了这些冠醚与手性胺的复合过程中温度依赖的对映选择性,并根据观察到的结合常数计算了复合的热力学参数。
    DOI:
    10.1039/a703452k
  • 作为产物:
    描述:
    2-[(2S)-1-phenylmethoxypropan-2-yl]oxypropan-1-ol 在 palladium on activated charcoal 吡啶氢气对甲苯磺酸 作用下, 以 乙醇 为溶剂, 25.0 ℃ 、101.33 kPa 条件下, 反应 3.5h, 生成 (2S,2'S)-oxybis(propane-2,1-diyl)bis(4-methylbenzenesulfonate)
    参考文献:
    名称:
    Preparation of optically active azophenolic crown ethers containing 1-phenylethane-1,2-diol and 2,4-dimethyl-3-oxapentane-1,5-diol as a chiral subunit: temperature-dependent enantiomer selectivity in the complexation with chiral amines 1
    摘要:
    采用(2S,4S)-2,4-二甲基-3-氧戊烷-1,5-二醇和(S)-或(R)-1-苯乙烷-1,2-二醇作为手性子单元,合成了具有两个苯基和两个甲基取代基以及p-(2,4-二硝基苯基偶氮)酚基团的光学活性偶氮酚类冠醚(S,S,S,S)-1、(R,S,S,R)-2、(S,S,S,S)-3和(R,S,S,R)-4,并且这些化合物以对映体纯形式制备。通过在氯仿中采用紫外-可见光光谱法研究了这些冠醚与手性胺的复合过程中温度依赖的对映选择性,并根据观察到的结合常数计算了复合的热力学参数。
    DOI:
    10.1039/a703452k
点击查看最新优质反应信息

文献信息

  • Betti's base for crystallization-induced deracemization of substituted aldehydes: synthesis of enantiopure amorolfine and fenpropimorph
    作者:Andrea Carella、Gabriel Ramos Ferronatto、Emanuela Marotta、Andrea Mazzanti、Paolo Righi、Claudio Paolucci
    DOI:10.1039/c6ob02765b
    日期:——
    diastereoisomer transformation (CIDT) of naphthoxazines derived from racemic O-protected 2-substituted 4-hydroxybutyraldehydes and enantiopure Betti's base allows the deracemization of the starting aldehydes with ee up to 96%. As an alternative, reduction with lithium aluminum hydride of the diastereoisomerically enriched naphthoxazines leads to enantioenriched primary amines. The utility of the latter strategy
    由外消旋的O-保护的2-取代的4-羟基丁醛和对映体纯的Betti's碱衍生的并恶嗪的酸促进结晶诱导的非对映异构体转化(CIDT)可以使起始醛与ee的反硝化作用高达96%。或者,用将非对映异构体富集的并恶嗪还原可得到对映体富集的伯胺。后一种方法的实用性通过将其应用于对映体富集的咪唑和ee高达99.5%的对映体纯阿莫罗芬的首次合成得到了证明。
  • Preparation of homochiral azophenolic crown ethers containing 1-phenylethane-1,2-diol and 2,4-dimethyl-3-oxapentane-1,5-diol as a chiral subunit: Enantiomer recognition behaviour towards chiral 2-aminoethanol derivatives
    作者:Koichiro Naemura、Kazuko Ogasahara、Keiji Hirose、Yoshito Tobe
    DOI:10.1016/s0957-4166(96)00472-7
    日期:1997.1
    Enantiomerically pure azophenolic crown ethers 1–4 containing (S)- or (R)-1-phenylethane-1,2-diol moieties and (2S,4S)-2,4-dimethyl-3-oxapentane-1,5-diol moiety as a chiral subunit were prepared; crown ethers (S,S,S,S)-1 showed high chiral recognition behaviour in complexation with 2-substituted 2-aminoethanol derivatives.
    对映体纯的偶氮酚冠醚1-4,含有(S)-或(R)-1-乙烷-1,2-二醇部分和(2 S,4 S)-2,4-二甲基-3-戊烷-1,5制备了作为手性亚基的-二醇部分;冠醚(S,S,S,S)-1在与2-取代的2-乙醇生物络合中显示出高手性识别行为。
  • Compounds and compositions as inhibitors of endosomal toll-like receptors
    申请人:Novartis AG
    公开号:US10954233B2
    公开(公告)日:2021-03-23
    The invention disclosed herein relates to 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridinyl compounds and 4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridinyl compounds of Formula (A), pharmaceutical compositions comprising such compounds and the use of such compounds in the treatment of autoimmune diseases.
    本发明涉及式(A)的4,5,6,7-四氢-1H-吡唑并[4,3-c]吡啶基化合物和4,5,6,7-四-2H-吡唑并[4,3-c]吡啶基化合物、包含此类化合物的药物组合物以及此类化合物在治疗自身免疫性疾病中的用途。
  • Visual Enantiomeric Recognition of Amino Acid Derivatives in Protic Solvents<sup>1</sup><sup>,</sup>
    作者:Kazunori Tsubaki、Daisuke Tanima、Mohammad Nuruzzaman、Tomokazu Kusumoto、Kaoru Fuji、Takeo Kawabata
    DOI:10.1021/jo050387u
    日期:2005.6.1
    [GRAPHICS]Various types of chiral host molecules 2-7 based on a phenolphthalein skeleton and two crown ethers were prepared for use in visual enantiomeric recognition, and we examined their enantioselective coloration in complexation with chiral amino acid derivatives 9-22 in methanol solution. Methyl-substituted host (S,S,S,S)-3 showed particularly prominent enantiomer selectivity for the alanine amide derivatives 11 and 12. A combination of methyl-substituted host (S,S,S,S)-3 with guest (R)-11 or (R)-12 developed a purple color, whereas no color development was observed with (S)-11 or (S)-12. On the other hand, phenyl-substituted host (S,S,S,S)-6 showed deeper coloration with a wide range of (S)-beta-amino alcohols compared to that seen with host (S,S,S,S)-6 and the corresponding (R)-beta-amino alcohols at 0 degrees C. Furthermore, absorbance inversion temperatures (AIT) were observed within the range of 0-50 degrees C in many cases.
  • Preparation and enantiomer recognition of chiral azophenolic crown ethers having three chiral barriers on each of the homotopic faces
    作者:Koichiro Naemura、Masaki Asada、Keiji Hirose、Yoshito Tobe
    DOI:10.1016/0957-4166(95)00240-p
    日期:1995.8
    Homochiral azophenolic crown ethers 1 and 2 having three chiral barriers, that is, the phenyl group, the methyl group, and the cyclohexane moiety on each of the homotopic faces have been prepared. The enantiomer recognition toward chiral 2-aminoethanol derivatives has been examined.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫